StreetInsider.com News Articles

Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

Thu, 14 Aug 2025 11:10:00 -0400

SAN FRANCISCO, Aug. 14, 2025 /PRNewswire/ -- Citizen Health, a patient-powered platform transforming rare disease care, announced today it has raised $30 million in Series A funding. The round was led by 8VC, with participation from Transformation Capital and Headline, bringing the company's total funding to $44 million since its December 2023 launch.

Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

Thu, 14 Aug 2025 11:10:00 -0400

Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

Thu, 14 Aug 2025 11:10:00 -0400

Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

Thu, 14 Aug 2025 11:10:00 -0400

Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

Thu, 14 Aug 2025 11:10:00 -0400

Citizen Health Raises $30 Million to Build AI Advocate for Every Patient, Ushering in a New Era of Patient-Centered Healthcare

Thu, 14 Aug 2025 11:10:00 -0400

Form SCHEDULE 13G/A Invitae Corp Filed by: ARK Investment Management LLC

Fri, 10 Jan 2025 21:17:00 -0400

si-local-file:///var/storage/secattach/20250110/24196051.html

Form SCHEDULE 13G/A Invitae Corp Filed by: ARK Investment Management LLC

Fri, 10 Jan 2025 21:17:00 -0400

si-local-file:///var/storage/secattach/20250110/24196051.html

Form 8-K Invitae Corp For: Aug 07

Thu, 08 Aug 2024 06:03:00 -0400

si-local-file:///var/storage/secattach/20240808/23568944.html

Form 8-K Invitae Corp For: Aug 07

Thu, 08 Aug 2024 06:03:00 -0400

si-local-file:///var/storage/secattach/20240808/23568944.html

Form 8-K Invitae Corp For: Aug 07

Thu, 08 Aug 2024 06:03:00 -0400

si-local-file:///var/storage/secattach/20240808/23568944.html

Labcorp (LH) Finalizes Acquisition of Select Assets of Invitae

Mon, 05 Aug 2024 07:02:00 -0400

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the completion of its acquisition of select assets of Invitae (OTC:NVTAQ), a leading medical genetics company. Together, Labcorp and Invitae will support patients, clinicians and pharmaceutical partners across the continuum of care, including therapy development, patient diagnosis and personalized care.

"Labcorp and Invitae are on a shared mission to harness the power of genetic insights to transform medicine, deliver personalized care and improve health outcomes," said Mark Schroeder, Executive Vice President and President of Diagnostics

Labcorp (LH) Finalizes Acquisition of Select Assets of Invitae

Mon, 05 Aug 2024 07:02:00 -0400

Labcorp (LH) Finalizes Acquisition of Select Assets of Invitae

Mon, 05 Aug 2024 07:02:00 -0400

Labcorp (LH) Finalizes Acquisition of Select Assets of Invitae

Mon, 05 Aug 2024 07:02:00 -0400

Labcorp (LH) Finalizes Acquisition of Select Assets of Invitae

Mon, 05 Aug 2024 07:02:00 -0400

Labcorp (LH) Finalizes Acquisition of Select Assets of Invitae

Mon, 05 Aug 2024 07:02:00 -0400

Labcorp Finalizes Acquisition of Select Assets of Invitae

Mon, 05 Aug 2024 07:00:00 -0400